Viewing Study NCT01439204


Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-01-04 @ 5:28 PM
Study NCT ID: NCT01439204
Status: COMPLETED
Last Update Posted: 2014-03-19
First Post: 2011-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IM101-292
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators